La melatonina reduce la respuesta de cortisol al ACTH en humanos
Open accessThe DOI matches its Crossref record; 35 of the 38 references it cites were found in a registry or an index; none of the 33 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Melatonin receptors are widely distributed in human tissues but they have not been reported in human adrenal gland. AIM: To assess if the human adrenal gland expresses melatonin receptors and if melatonin affects cortisol response to ACTH in dexamethasone suppressed volunteers. MATERIAL AND METHODS: Adrenal glands were obtained from 4 patients undergoing unilateral nephrectomy-adrenalectomy for renal cancer. Expression of mRNA MT1 and MT2 melatonin receptors was measured by Reverse TranscriPtase Polymerase Chain Reaction (RT-PCR). The effect of melatonin on the response to intravenous (i.v.) ACTH was tested (randomized cross-over, double-blind, placebo-controlled trial) in eight young healthy males pretreated with dexamethasone (1 mg) at 23:00 h. On the next day, at 08:00 h, an i.v. line was inserted, at 08:30 h, and after a blood sample, subjects ingested 6 mg melatonin or placebo. At 09:00 h, 1-24 ACTH (Cortrosyn, 1 microg/1.73 m2 body surface area) was injected, drawing samples at 0, 15, 30, 45 and 60 minutes after. Melatonin, cortisol, cortisone, progesterone, aldosterone, DHEA-S, testosterone and prolactin were measured by immunoassay. RESULTS: The four adrenal glands expressed only MT1 receptor mRNA. Melatonin ingestion reduced the cortisol response to ACTH from 14.6 +/- 1.45 microg/dl at 60 min in the placebo group to 10.8 +/- 1.2 microg/dl in the melatonin group (p < 0.01 mixed model test). It did not affect other steroid hormone levels and abolished the morning physiological decline of prolactin. CONCLUSIONS: The expression of MT1 melatonin receptor in the human adrenal, and the melatonin reduction of ACTH-stimulated cortisol production suggest a direct melatonin action on the adrenal gland.
Overview
CoChat Summary
TL;DR
In dexamethasone-suppressed healthy young men, a single 6 mg oral dose of melatonin reduced the cortisol response to ACTH, and human adrenal tissue expressed MT1 but not MT2 melatonin receptor mRNA. Melatonin also prevented the morning decline in prolactin without significantly affecting other measured adrenal steroids.
Key findings
- Human adrenal glands from 4 patients expressed only MT1 receptor mRNA; MT2 mRNA was not detected in adrenal tissue, whereas the renal positive control expressed both MT1 and MT2. The MT1 PCR product matched bases 477–912 of human MT1 mRNA.
- In 8 dexamethasone-suppressed healthy males, melatonin reduced ACTH-stimulated cortisol: 14.6 ± 1.45 µg/dl at 60 min with placebo vs 10.8 ± 1.2 µg/dl with melatonin (p < 0.01 mixed model in the abstract; results report lower values at 45 and 60 min, p < 0.05 mixed models). The effect was observed in 7 of 8 subjects.
- Melatonin did not significantly affect cortisone, progesterone, aldosterone, DHEA-S, or testosterone responses to ACTH. It abolished the morning physiological decline of prolactin, with higher prolactin than placebo from 30 to 60 min post-ACTH (p < 0.01 mixed models).
- Plasma melatonin rose after 6 mg and remained elevated throughout the ACTH test (e.g., 10,778.1 ± 2,210.1 pg/ml at +30 min vs 52.1 ± 3.7 pg/ml with placebo).
Methods
- Adrenal tissue was obtained from 4 patients undergoing unilateral nephrectomy-adrenalectomy for renal cancer; MT1 and MT2 melatonin receptor mRNA expression was measured by RT-PCR, and the MT1 product was sequenced.
- The acute effect of melatonin on ACTH-stimulated steroidogenesis was tested in a randomized, double-blind, placebo-controlled crossover trial in 8 clinically healthy, non-obese males aged 24–34 years (BMI 24.8 ± 0.75 kg/m²). Subjects received dexamethasone 1 mg at 23:00 h, then 6 mg melatonin or placebo at 08:30 h, followed by 1-24 ACTH (1 µg/1.73 m² body surface area, i.v.) at 09:00 h; blood was sampled at 0, 15, 30, 45, and 60 min.
- Hormones were measured by immunoassay. Time courses were analyzed by one-way repeated-measures ANOVA with Tukey tests, and placebo vs melatonin comparisons used mixed models (SAS); significance was set at p < 0.05.
Limitations
- The authors state that the experimental design does not allow establishing whether the in vivo reduction in cortisol response to ACTH was due to direct actions on the adrenal gland, although adrenal MT1 expression opens that possibility.
- The authors note that differences from prior in vitro primate adrenal studies may be due to protocol duration, since in vitro exposure to ACTH and melatonin was 48 h.
- Evident from the text: the study used very small samples (4 adrenal glands and 8 male volunteers) and included only young healthy men, limiting generalizability to women, older adults, or clinical populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
0 Valid · 0 Not valid · 14 Not checked · 18 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“La glándula suprarrenal humana expresa el receptor MT1 de melatonina como se observa en la Figura 1.”
- Also stated in: § Melatonin reduces cortisol response to ACTH in humans · p. 1 · plain
“The four adrenal glands expressed only MT1 receptor mRNA.”
- Also stated in: § DISCUSIÓN · p. 6 · plain
“encontramos por primera vez la expresión del mARN del receptor MT1 en las 3 muestras analizadas de tejido suprarrenal normal y en una de adenoma suprarrenal.”
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Melatonin reduces cortisol response to ACTH in humans · p. 1 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“no se detectó la expresión del mARN del receptor MT2 en suprarrenal”
- Also stated in: § Melatonin reduces cortisol response to ACTH in humans · p. 1 · plain
“The four adrenal glands expressed only MT1 receptor mRNA.”
- Also stated in: § DISCUSIÓN · p. 6 · plain
“La expresión del mARN del receptor MT2 no se detectó en ninguna de las muestras de tejido suprarrenal, usando las mismas concentraciones de cADN usadas para analizar el receptor MT1.”
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Melatonin reduces cortisol response to ACTH in humans · p. 1 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Melatonin ingestion reduced the cortisol response to ACTH from 14.6 ± 1.45 µ g/dl at 60 min in the placebo group to 10.8 ± 1.2 µ g/dl in the melatonin group (p <0.01 mixed model test).”
- Also stated in: § REFERENCIAS · p. 7 · plain
“la ingestión de melatonina disminuye en forma aguda la producción de cortisol estimulada por ACTH en sujetos suprimidos con dexametasona.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § REFERENCIAS · p. 7 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“La melatonina no modificó las concentraciones basales de ninguno de los esteroides ni la respuesta de cortisona, aldosterona y progesterona al ACTH (Tabla 2).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“La secuencia de este producto fue idéntica a la secuencia entre las bases 477-912 del mARN del receptor MT1 de melatonina correspondiente a los dominios transmembrana 3-6 de la proteína”
What the sources say
- Not checked — no full text of the sourcecites [29] REPPERT SM, WEAVER DR, EBISAWA T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13: 1177-85. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
8 more claims
Create a free account to see all 32 claims and every source verdict.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 12
Citations
Cites
Littell, R. C., Milliken, G. A., Stroup, W. W., Wolfinger, R. D., & Schabenberger, O. (2006) · CERN Document Server (European Organization for Nuclear Research) · Cited by 2,924
Brzezinski, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360306 · Cited by 1,549
Reppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096
Arendt, J., & Skene, D. J. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.05.002 · Cited by 629
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Melatonin receptors in humans: biological role and clinical relevance
Ekmekcioglu, C. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.01.002 · Cited by 370
Bornstein, S. R., & Chrousos, G. P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5631 · Cited by 354
Light Affects Morning Salivary Cortisol in Humans
Scheer, F. A. J. L. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3395 · Cited by 268
Direct Action of Melatonin in Human Granulosa-Luteal Cells
Woo, M. M. M., Tai, C.-J., Kang, S. K., Nathwani, P. S., Pang, S. F., & Leung, P. C. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4789 · Cited by 240
Leproult, R., Colecchia, E. F., L’Hermite-Balériaux, M., & Van Cauter, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7102 · Cited by 203
Cited by
The effects of shift work on physical and mental health
Vogel, M., Braungardt, T., Meyer, W., & Schneider, W. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0800-4 · Cited by 198
“Apart from the natural immunosuppressive function of glucocorticoids, although opposed by some alleged partial synergism, there are also interactions between melatonin and glucocorticoids in form of a suppressive effect on ACTH-induced glucocorticoid production (Campino et al. 2008).”
BackgroundKhan, S., Duan, P., Yao, L., & Hou, H. (2018) · International Journal of Genomics · doi:10.1155/2018/8576890 · Cited by 107
Benefits and adverse events of melatonin use in the elderly (Review)
Anghel, L., Baroiu, L., Popazu, C., Pătraș, D., Fotea, S., Nechifor, A., Ciubară, A., Nechita, L., Mușat, C. L., Ștefanopol, I. A., et al. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11142 · Cited by 71
Komatsubara, M., Hara, T., Hosoya, T., Toma, K., Tsukamoto-Yamauchi, N., Iwata, N., Inagaki, K., Wada, J., & Otsuka, F. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.002 · Cited by 33
Ghareghani, M., Pons, V., Laflamme, N., Zibara, K., & Rivest, S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00925-1 · Cited by 19
Metadata
- Authors
- Campino, C., Valenzuela, F., Arteaga, E., Torres-Farfán, C., Trucco, C., Velasco, A., Guzmán, S., & Serón-Ferré, M.
- Affiliations
- Pontificia Universidad Católica de Chile (CL)
- University of Chile (CL)
- Venue
- Revista medica de Chile
- Published
- 2008-11
- Volume
- 136
- Issue
- 11
- Pages
- 1390-7
- ISSN
- 0034-9887 (ISSN-L)
- OpenAlex
- W2136849615
- Cited by
- 23
- References
- 38
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 3 · 2022: 1 · 2020: 2 · 2018: 2 · 2016: 2 · 2015: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Revista médica de Chile (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, cc-by)
- Universidad de Chile (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- melatonin, melatonin receptors, MT1 receptor, adrenal gland, ACTH stimulation test, cortisol, dexamethasone suppression, adrenal steroidogenesis, prolactin
- MeSH terms
- Adrenal Glands, Adrenocorticotropic Hormone, Adult, Dexamethasone, Double-Blind Method, Glucocorticoids, Humans, Hydrocortisone, Immunoassay, Male, Melatonin, RNA, Messenger, Time Factors, Cross-Over Studies, Reverse Transcriptase Polymerase Chain Reaction, Receptor, Melatonin, MT1, Receptor, Melatonin, MT2, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: La melatonina reduce la respuesta de cortisol al ACTH en humanos. https://app.cochat.ai/papers/10.4067/s0034-98872008001100004
- The paper
- Campino, C., Valenzuela, F., Arteaga, E., Torres-Farfán, C., Trucco, C., Velasco, A., Guzmán, S., & Serón-Ferré, M. (2008). La melatonina reduce la respuesta de cortisol al ACTH en humanos. Revista medica de Chile. https://doi.org/10.4067/s0034-98872008001100004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.